Wednesday, January 08, 2020 8:29:38 AM
Will see what SOON has to say SOON enough (next Tuesday), although I doubt there will be anything significant relating to CYTR. We have to understand that the BIG NEWS we are anticipating still may be weeks or months off so it will be important for me to keep a close watch on CYTR's PPS over that period of time as I still have thousands of shares UP over 100%, and I'd feel very badly to see those profits quickly disappear as we did in Jul 2017.
I agree with you that Arimoclomol alone will never increase CYTR's PPS to the levels most "Longs" need to break even. IMO, only Aldox's FDA approval, manufacture and commercialization will be able to do that and MUCH MORE! My avg has increased to $1.25 with my recent sales of my lowest priced shares, but thus far, I don't regret reducing my share count just a bit. I still have thousands of shares I bought far below the current PPS that are at risk of being sold if and when the situation arises. Hopefully CYTR breaks a $1 or more this week. Will see how things go today.
All IMO. GL 2 US & CYTR!
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM